Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Deciphera Pharmaceuticals Inc 200 SMITH STREET Waltham MA 02451 USA

www.deciphera.com P: 781-209-6400 F: 785-830-2150

Description:

Deciphera Pharmaceuticals, Inc. develops small molecule kinase inhibitors for cancer, utilizing its proprietary kinase switch control inhibitor platform.

Key Statistics

Overview:

Market Capitalization, $K 2,086,896
Enterprise Value, $K 2,003,386
Shares Outstanding, K 82,226
Annual Sales, $ 163,360 K
Annual Net Income, $ -194,940 K
Last Quarter Sales, $ 48,290 K
Last Quarter Net Income, $ -47,190 K
EBIT, $ -210,970 K
EBITDA, $ -208,870 K
60-Month Beta 0.20
% of Insider Shareholders 4.43%
% of Institutional Shareholders 70.96%
Float, K 78,583
% Float 95.57%
Short Volume Ratio 0.30

Growth:

1-Year Return 82.20%
3-Year Return 195.72%
5-Year Return 341.20%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 18.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 02/06/24
Latest Earnings Date 05/01/24
Earnings Per Share ttm -2.29
EPS Growth vs. Prev Qtr 6.90%
EPS Growth vs. Prev Year 10.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 11/05/21

DCPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -49.44%
Return-on-Assets % -38.41%
Profit Margin % -119.33%
Debt/Equity 0.00
Price/Sales 12.78
Price/Cash Flow N/A
Price/Book 5.79
Book Value/Share 4.38
Interest Coverage -0.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar